| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/01/2005 | EP1535512A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARa GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 06/01/2005 | EP1534707A1 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 06/01/2005 | EP1534703A2 Antagonists of melanin concentrating hormone receptor |
| 06/01/2005 | EP1534687A1 Pyrimidine compounds |
| 06/01/2005 | EP1534681A1 Substituted quinoline ccr5 receptor antagonists |
| 06/01/2005 | EP1534676A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 06/01/2005 | EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 06/01/2005 | EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 06/01/2005 | EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 06/01/2005 | EP1534389A2 Pyrazolopyrimidines as kinase inhibitors |
| 06/01/2005 | EP1534297A1 Methods of treatment of male erectile dysfunction |
| 06/01/2005 | EP1534290A2 Novel inhibitors of kinases |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/01/2005 | EP1534258A2 AGONISM OF THE 5HT 2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION |
| 06/01/2005 | EP1534256A2 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534248A1 Lasofoxifene tablet and its coating |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1335730B1 Use of pde5 inhibitors for the treatment of premature ejaculation |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1131061B1 Agent for lowering prolactin |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | CN1622938A 方法 Method |
| 06/01/2005 | CN1622830A Peptide-based compounds |
| 06/01/2005 | CN1621094A Gene transfer for regulating smooth muscle tone |
| 06/01/2005 | CN1621081A Preparation of isotomic injecta containing cordate houttuynia and honeysuckle flower and its preparation method |
| 06/01/2005 | CN1621047A Medicine for treating hysteromyoma |
| 06/01/2005 | CN1621033A Method for producing multiple in-phase mature ovum by diethyl stilbestrol |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1203876C Medicine for treating postpartum subinvolution of uterus and its preparation method |
| 06/01/2005 | CN1203868C External-use disinfecting medicinal preparation for women |
| 06/01/2005 | CN1203858C Pharmaceutically active morpholinol |
| 06/01/2005 | CN1203852C Valdecoxib compositions |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900338 Scavenger compounds |
| 05/31/2005 | US6900336 8-aza-11-deoxy prostaglandin analogues |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900309 Aminocarbonylation reaction of a adenosine compound containing purine base and pentofuranosyl sugar and a leaving group at 2 position of purine ring, with an amine compound in presence of carbon monoxide and suitable coupling catalyst |
| 05/31/2005 | US6900243 Phenylheteroalkylamine derivatives |
| 05/31/2005 | US6900240 Enriched in at least two of the phytochemicals selected from the group consisting of isoflavones, lignans, saponins, catechins and phenolic acids. |
| 05/31/2005 | US6900216 Psychological disorders; antidepressants; brain diosrders; anticonvulsants |
| 05/31/2005 | US6900212 Anxiolytic agents; psychological disorders; sexual disorders; eating disorders |
| 05/31/2005 | US6900200 Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 05/31/2005 | US6900038 eNOS mutations useful for gene therapy and therapeutic screening |
| 05/31/2005 | US6899900 Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 05/31/2005 | US6899896 Hydrogel-driven layered drug dosage form |
| 05/31/2005 | US6899894 Mixture of oestradiol and norethisterone acetate applied to backing with pressure sensitive adhesive; protective coatings; multilayer |
| 05/31/2005 | US6899890 Bioadhesive drug delivery system |
| 05/31/2005 | US6899888 Suppressing bone disordes such as decalcification or fractures in humans having prostate gland cancers by administering antiestrogen selected from triphenylethylene or toremifene; hormone inhibitors |
| 05/31/2005 | US6899700 Therapeutic agent delivery tampon |
| 05/26/2005 | WO2005047251A1 Melanocortin receptor agonists |
| 05/26/2005 | US20050113577 Such as hydrochloride salt 3-[5-(4-methanesulfonyl-piperazin-1-yl-methyl)-1H-indol-2-yl]-1H-quinolin-2-one; signal transduction; for treatment of angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, and inflammatory diseases |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050113402 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 05/26/2005 | US20050113386 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 05/26/2005 | US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic |
| 05/26/2005 | US20050113358 Enzyme inhibitors for erectile dysfunction and sexual disorders |
| 05/26/2005 | US20050113299 Protein a compositions and methods of use |
| 05/26/2005 | US20050112575 Nucleic acid sequence encoding polypeptides; triggering calcium oscillation in ooctyes ; determination fertility |
| 05/26/2005 | US20050112565 Proteases |
| 05/26/2005 | US20050112147 Administering a neurotoxin |
| 05/25/2005 | EP1532985A1 Process for producing sustained-release composition |
| 05/25/2005 | EP1532238A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/25/2005 | EP1532144A1 Novel quinuclidine derivatives and their use |
| 05/25/2005 | EP1532109A1 Pyrrolidine derivatives as oxytocin antagonists |
| 05/25/2005 | EP1532104A1 Crystalline beta-2 adrenergic receptor agonist |
| 05/25/2005 | EP1531867A1 Metastable pharmaceutical compositions |
| 05/25/2005 | EP1531847A2 Pharmaceutical formulation |
| 05/25/2005 | EP1531843A1 Method for treating cervical cancer |
| 05/25/2005 | EP1531829A2 Infertility treatment with exemestane |
| 05/25/2005 | EP1531824A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 05/25/2005 | EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors |
| 05/25/2005 | EP1531806A2 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 05/25/2005 | EP1341791B1 Thioether substituted imidazoquinolines |
| 05/25/2005 | EP1322286B1 Polymeric delivery formulations of leuprolide with improved efficacy |
| 05/25/2005 | EP1279039A4 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1) |
| 05/25/2005 | EP0907652B1 Immunosuppressive compounds and methods |
| 05/25/2005 | CN1620499A Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux |
| 05/25/2005 | CN1620467A Secreted protein |
| 05/25/2005 | CN1620459A 稠合双环嘧啶衍生物 Fused bicyclic pyrimidine derivative |
| 05/25/2005 | CN1620458A 噻吩并嘧啶 Thienopyrimidine |
| 05/25/2005 | CN1620457A Tetracyclic heterocompounds as estrogen receptor modulators |
| 05/25/2005 | CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 05/25/2005 | CN1620440A Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 05/25/2005 | CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1620302A Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12 |
| 05/25/2005 | CN1620298A Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
| 05/25/2005 | CN1618438A Medicinal liquor for cleaning leukorrhagia and relieving itching |
| 05/25/2005 | CN1618423A Medicine used for dilatating woman's cervix |
| 05/25/2005 | CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/25/2005 | CN1202868C Bacterial medical nano suppository for woman and its preparing process |
| 05/25/2005 | CN1202849C Oral liquid for nephrosis |
| 05/25/2005 | CN1202823C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (NIDDM) attack |
| 05/25/2005 | CN1202821C Use of thiazolidinedione for preventing or retaining non-insulin-dependent diabets mellitus (MIDDM) attack |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6897239 New use of existing pharmaceutical misoprostol antiulcer agent, has a strong local vasodilation effect on applied tissue; a synergic action with combining alprostadil |